Open Access

A novel synthetic ursolic acid derivative inhibits growth and induces apoptosis in breast cancer cell lines

  • Authors:
    • Wei Li
    • Hongxiu Zhang
    • Mingxiu Nie
    • Wei Wang
    • Zongtao Liu
    • Ceshi Chen
    • Haijun Chen
    • Rong Liu
    • Zulqarnain Baloch
    • Ke Ma
  • View Affiliations

  • Published online on: December 11, 2017     https://doi.org/10.3892/ol.2017.7578
  • Pages:2323-2329
  • Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

The present study investigated the anticancer functions of ursolic acid (UA) and its novel derivatives, with a nitrogen‑containing heterocyclic scaffold and the privileged fragment at the C‑28 position on apoptosis induction, cell proliferation and cell cycle in human BC lines. UA was chemically modified in the present study to increase its antitumor activity and bioavailability. A novel UA derivative, FZU3010, was synthesized using a nitrogen‑containing heterocyclic scaffold and a privileged fragment at the C‑28 position. Sulforhodimine B assays were used to measure the effect of UA and different concentrations of FZU3010 on the viability of breast cancer (BC) SUM149PT and HCC1937 cells. FZU3010 significantly repressed the proliferation of the two cancer cell lines in a dose‑dependent manner, with a half‑maximal inhibitory concentration of 4‑6 µM, and exhibited decreased cytotoxicity compared with vehicle‑treated cell lines. The effect of FZU3010 on cell cycle distribution and cellular apoptosis was also investigated. The results of this investigation indicated that FZU3010 significantly increased the number of SUM149PT and breast cancer HCC1937 cells in the G0/G1 phase in a dose‑dependent manner. Additionally, at a concentration of 5 µM, the capability of FZU3010 to induce BC apoptosis was significantly higher than the capability of UA. Thus, the results of the current study indicated that FZU3010 induced apoptosis in BC cells, together with induction of cell cycle arrest at the S and G0/G1 phase. FZU3010 may therefore be considered as a potential therapeutic agent for the treatment of BC.

Related Articles

Journal Cover

February 2018
Volume 15 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

2016 Impact Factor: 1.39
Ranked #68/217 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Li, W., Zhang, H., Nie, M., Wang, W., Liu, Z., Chen, C. ... Ma, K. (2018). A novel synthetic ursolic acid derivative inhibits growth and induces apoptosis in breast cancer cell lines. Oncology Letters, 15, 2323-2329. https://doi.org/10.3892/ol.2017.7578
MLA
Li, W., Zhang, H., Nie, M., Wang, W., Liu, Z., Chen, C., Chen, H., Liu, R., Baloch, Z., Ma, K."A novel synthetic ursolic acid derivative inhibits growth and induces apoptosis in breast cancer cell lines". Oncology Letters 15.2 (2018): 2323-2329.
Chicago
Li, W., Zhang, H., Nie, M., Wang, W., Liu, Z., Chen, C., Chen, H., Liu, R., Baloch, Z., Ma, K."A novel synthetic ursolic acid derivative inhibits growth and induces apoptosis in breast cancer cell lines". Oncology Letters 15, no. 2 (2018): 2323-2329. https://doi.org/10.3892/ol.2017.7578